The research-context dosing references for each compound live on their respective protocol pages: the BPC-157 10 mg vial research dosage reference and the TB-500 10 mg vial research dosage reference
Summary: Shortness of breath is not a recognised common side effect of Ozempic according to UK regulatory data, though indirect mechanisms such as gastrointestinal distension or rare allergic reactions may occasionally contribute to respiratory symptoms
Quick decision guide: Methylcellulose (Citrucel-type fiber) best for people who want less gas and bloating Psyllium (Metamucil-type fiber) best for stronger stool bulk and cholesterol support Taking Ozempic, Wegovy, Zepbound, Mounjaro or Retatrutide
These analogues, particularly basal Insulin analogs like Insulin detemir and Insulin glargine, offer numerous benefits, including less variability, longer duration of action, and reduced risk of hypoglycemia, especially at night
Bi-weekly cadence, 4 to 6 months for measurable change
First comes a medical assessment, where a clinician reviews your health profile to determine whether GLP-1 therapy is appropriate for you at all - HumeCare's own copy describes this as starting "with clinical suitability, not assumptions." If you're approved, HumeCare states your prescribed medication ships along with your Hume Pod, and the Pod begins tracking body composition changes
